Bharat Biotech Submits Data On Covid-19 Vaccine Trial In Children
NDTV
The Drugs Controller General of India last month allowed vaccine maker Serum Institute to enroll kids aged 7 to 11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
Bharat Biotech said on Wednesday it had submitted data from its Covid-19 vaccine trial in children aged 2 to 18 years to the drug regulator, becoming the country's first company to have tested its shot in very young children.
India is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
The Drugs Controller General of India last month allowed vaccine maker Serum Institute to enroll kids aged 7 to 11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
